Table 1 Characterization of the stakeholders in the current project
Stakeholder group | Profile | Identification of motivations and objectives | Solution benefits | Importance | Influence | Relationship with other stakeholders |
|---|---|---|---|---|---|---|
Patients | Individuals submitted to cardiac surgery and were selected for the digital telemonitoring follow-up. | Be safe and in surveillance by the clinical team; have a successful recovery. | Increased patient’s perception of safety; increased participation through recovery; better adherence to the clinical recommendations. | High | Medium | Surgeons and nurses; Family caregiver; R&D team. |
Family caregiver | Patient’s relative that is providing support to the patient along with the follow-up | Support the patient in successful recovery; be supported in patient’s care. Guarantee that the patient is well treated. | Ensure the best patient recovery and clinical support; be aware of the patient’s health status; accessibility to care delivery. | Medium | Low | Patients; Surgeons and nurses; R&D team. |
Surgeons and nurses from the cardiothoracic department | Healthcare professionals providing healthcare services. | Improve patients’ reassurance; improve outcomes through recovery; be informed about patient’s status to detect complications early. | Decrease the number of critical incidents; increase patient’s perception of safety; ability to close monitor a higher group of patients. | High | High | Patients; Family caregiver; R&D team. |
R&D team | R&D organization that ensures that the technological pilot adds value to the digital health service provided and meets the stakeholders’ needs. | Provide a valid solution to the actual healthcare context. Study the value of a digital telemonitoring service in healthcare. | Development of new methods to effectively collect outcomes in outpatient environments; assessment of the solution’s impact. | High | High | Patients; Family caregivers; Surgeons and nurses; DHK providers. |
DHK provider | Fraunhofer AICOS, an R&D organization providing technology research; Vodafone Portugal, a telecommunications operator. | Provide solutions that are usable, interoperable, safe, and compatible with medical device regulation. Provide tools for digital transformation in healthcare. | Development and validation of digital solutions; value assessment of new digital products; collaboration with partners. | High | Low | R&D team |